Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 349 results for "glenmark pharmaceuticals"

GLAXOSMITHKL 6278.50

GLENMARK PHA 1009.80 GMR INFRASTR 14.02 GODREJ CONS 1370.45 GODREJ IND 389.95 GODREJ PROP 268.65 GPPL 235.70 GRASIM IND. 3708.65 GREAT EASTE 347.85 GRUH FINANCE 243.65 GUJ PETRONET 129.40 GUJ.MINERAL 91.10 GUJ.ST.FERT 73.20 GVK POWERINF 9.02 HATHWAY ... Sify, 22 hours ago
PTI - STOCK-MUM-CLOS 5 - GLAXOSMITHKL Namibia Press Agency, 1 month ago
Livemint.com

Glenmark consolidated net improves marginally by 3.3% in Q1

Glenmark Pharmaceuticals, a Rs. 6595 crore pharma major, has managed to improve its consolidated net sales by 3.3 per cent to Rs. 190.97 crore during the first quarter ended June 2015 as against Rs. 184.85 crore in the corresponding period of last ...
 PharmaBiz1 day ago Glenmark Pharma gains after reporting decent Q1 results  Capital Market1 day ago Glenmark profit up 3.3%  Business Standard2 days ago Glenmark Pharma Q1 net up 3%  Hindu Business Line2 days ago
[x]  

Glenmark up 6%; maintains guidance of 18-20% revenue growth

It feels that US sales may see a pick-up in Q2. The company is also planning to file atleast 17-18 ANDAs in US this fiscal. However, volatility in emerging market currencies and consistent drop in sales in Venezuela remain a concern for the company.
 Money Control1 day ago Glenmark: Revenue growth in recovery mode  Business Standard1 month ago

Glenmark shares surge nearly 6% on bourses

r the company posted rise in consolidated net profit for the first quarter ended June 30. After surging 6.87 per cent to Rs 1,022 in intra-day trade at the BSE, shares of the company finally ended at Rs 1,009.80, up 5.59 per cent. At the NSE, the company's ...
 Business Standard1 day ago

Be stock-specific; prefer Dr Reddy's, Lupin among pharma names: Pankaj Pandey

, Head of Research, ICICIdirect.com, shares his view on pharma stocks. ET Now: I do not know how closely you look at Glenmark, but the trend that we have seen in pharma, is that bad numbers from Lupin, Sun Pharma and Glenmark have been punished, while good ...
 Economic Times1 day ago 'Monsoon, China much bigger concerns than Greece'  Economic Times4 weeks ago

US will be a strong driver for the company in the next few years: Glenn Saldanha, Glenmark Pharmaceuticals Ltd

In an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals Ltd, talks about his views on business in the US and other geographies. Excerpts: ET Now: How many products were launched in the US market during ...
 Economic Times1 day ago

Glenmark Pharma surges 6% post Q1 earnings

NEW DELHI: Shares of drugmaker Glenmark Pharmaceuticals surged over 6 per cent in trade on Friday, a day after the company posted an 11% rise in its first quarter revenue, driven by sales in India and Latin American markets. The stock hit an ...
 Economic Times1 day ago Glenmark Pharma surges over 6% post Q1 earnings  Economic Times1 day ago
MedIndia

Generic rosacea treatment infringed Bayer's Finacea® Gel

[Back To Home] [Back To Archives] From Intellectual Property Law Daily , July 28, 2015 By Jody Coultas, J.D. Glenmark Pharmaceuticals Limited infringed a patent covering a hydrogel treatment for mild to moderate rosacea distributed by Bayer ...
 Wolters Kluwer Law & Business2 days ago Glenmark's Patent Plea For Skin Care Drug Rejected By The US District Court Of Delaware  MedIndia3 days ago Glenmark Pharma slumps 4%; US Court rules against Finacea generic  India Infoline4 days ago Glenmark Pharma says: Court decision has no material impact on company  India Infoline3 days ago
[x]  

Glenmark Pharmaceuticals standalone net profit rises 222.52% in the June 2015 quarter

Sales rise 106.65% to Rs 1225.90 crore Net profit of Glenmark Pharmaceuticals rose 222.52% to Rs 335.20 crore in the quarter ended June 2015 as against Rs 103.93 crore during the previous quarter ended June 2014. Sales rose 106.65% to Rs 1225.90 crore in the ...
 Business Standard2 days ago

Dr Reddy's, Britannia to get astro support: Gupta

Pharma stocks like Dr Reddy's Laboratories, Divis Laboratories, Glenmark Pharma, Wockhardt and Brooks Lab to get astro support, says Satish Gupta of astrostocktips.
 Money Control2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glenmark pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less